The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

UL Expands South Bend, Indiana Laboratory to Add Non-Clinical Testing Capabilities

February 12, 2013 10:43 am | by The Associated Press | Underwriters Laboratories Inc. | News | Comments

Feb. 12, 2013 /PRNewswire-USNewswire/ -- UL (Underwriters Laboratories), a world leader in advancing safety, announced today the expansion of the South Bend, Indiana analytical laboratory to offer non-clinical testing services for the medical device industry.

TissueGen and Biomedical Structures Announce Availability of Breakthrough Drug Delivery Platform for Implantable Devices

February 12, 2013 10:00 am | by The Associated Press | News | Comments

TissueGen® Inc., developer of a cutting-edge absorbable polymer technology for implantable drug delivery across a wide variety of therapeutic applications, today announced that its patented extrusion technology enables absorbable fibers to be loaded with a wider variety of...


AxioMed® Spine Corporation Announces Freedom® Cervical Disc European Introduction

February 12, 2013 9:09 am | by The Associated Press | News | Comments

GARFIELD HEIGHTS, Ohio--(BUSINESS WIRE)--Feb 12, 2013--AxioMed ® Spine Corporation ( ) announces the commercial introduction of its Freedom ® Cervical Disc in Europe with a successful implantation in Switzerland. The Freedom Cervical Disc received CE Mark in 2012. AxioMed will also...


SunTech Medical Passes Testing at 2013 IHE Connectathon

February 12, 2013 9:00 am | by The Associated Press | News | Comments

MORRISVILLE, N.C.--(BUSINESS WIRE)--Feb 12, 2013--SunTech Medical has successfully passed multiple interoperability tests during 2013 IHE North American Connectathon (Chicago, Ill.)—part of the company’s strategy to develop medical products that can easily share data with different electronic...

Modulus Expands Offerings with Patch Design and Manufacturing

February 12, 2013 8:02 am | by The Associated Press | News | Comments

Modulus, a medical device manufacturing company, today announced it is expanding its capabilities to include patch design and manufacturing.  The company is offering custom patch design for applications ranging from iontophoretic drug delivery to patches for physiological sensing with or...


Secant Medical Expands Polymer Synthesis and Analytical Capabilities with New Lab

February 12, 2013 8:00 am | by The Associated Press | Secant Medical, Inc. | News | Comments

PERKASIE, Pa.--(BUSINESS WIRE)--Feb 12, 2013--Secant Medical® has established a new lab to perform polymer synthesis and analytical characterization of polymers, biomaterials and fibers. The analytical and polymer synthesis lab boosts Secant Medical’s in-house services for clients and enhances its...

Healthcare fraud recovery pays for itself - and then some | On Call

February 12, 2013 7:29 am | by Mass Device | News | Comments

For every $1 regulators spend fighting healthcare fraud and abuse during the last 3 years they recovered a record $7.90, the highest 3-year average return to date. Healthcare fraud prevention programs collected $4.2 billion in fiscal year 2012, up from about $4.1 billion in 2011. Over the last 4 years the policing initiatives have recovered $14.9 billion, according to an official report.

Sherrie Glasser-Mayrsohn: Physical Therapy Performed in Intensive Care Units Improves Patient Outcomes

February 12, 2013 6:24 am | by Bio-Medicine.Org | News | Comments

NEW YORK , Feb. 12, 2013 /PRNewswire-iReach/ -- Science Daily has recently released an article that explains the value of physical therapy when performed in the intensive care unit (ICU). While the use of physical therapy at such an early stage in a patient's recovery has not always been accepted, the article asserts that researchers from Johns Hopkins have revealed that the ability to reduce...


Paragonix Technologies, Inc., Announces Clearance of a 510(k) Pre-Marketing Notification Application with the US Food and Drug Administration for the Paragonix Sherpa™ Cardiac Transport System

February 12, 2013 6:00 am | by The Associated Press | News | Comments

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 12, 2013--Paragonix Technologies, Inc. today announced that it has received clearance for its Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration (FDA) for its Paragonix Sherpa Pak™ Cardiac Transport System 1 (CTS). The...


Trovagene Announces Commercial Launch Timelines for HPV Carrier and Oncogene Mutation Tests

February 12, 2013 5:27 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO , Feb. 12, 2013 /- Trovagene, Inc. (NASDAQ:  TROV) today announced that the development of its proprietary, urine-based HPV carrier screening test is progressing well and the Company expects to achieve analytical and clinical validation of the test in its CLIA laboratory in March 2013. When validation is completed, the test will be available to clinicians and...


Market Research Report -- New Opportunities for Needle-Free Injection Market

February 12, 2013 4:09 am | by The Associated Press | News | Comments has announced the addition of the market research report "The World Market for Injectable, Implantable and Needle-Free Drug Delivery Systems" to their product offering. All segments of the drug delivery arena are experiencing rapid evolution. This is particularly...


Class I Medical Device Recall: St. Jude Medical, AMPLATZER TorqVue FX Delivery System

February 12, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

On January 17, 2013, St. Jude Medical sent an “Urgent Medical Device Recall Notice” to their customers. The letter advised customers to stop using the device and remove it from their inventory. St. Jude Medical plans to have their sales representatives perform site visits to assist with recall activities, including completion of the product reconciliation form and return of any unused product.


Palomar Medical Gains on Swing to Q4 Black

February 11, 2013 6:49 pm | by Mass Device | News | Comments

Fourth-quarter profitability sends shares of Palomar Medical up nearly 5% on Wall Street today. Palomar Medical (NSDQ:PMTI) gained on Wall Street today after a swing to 4th-quarter profits bested Wall Street's earnings expectations by 1 thin dime.


ArthroCare to Host Conference Call on February 14, 2013

February 11, 2013 4:27 pm | by The Associated Press | News | Comments

AUSTIN, Texas--(BUSINESS WIRE)--Feb 11, 2013--ArthroCare Corporation (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to release its fourth quarter and year end 2012 results on Thursday, February 14, 2013. ArthroCare will host a conference call...


Weight Loss: EnteroMedics Shares Tank After Device "Fails" Study

February 11, 2013 2:42 pm | by Mass Device | News | Comments

Weight loss devices maker EnteroMedics loses half of its Wall Street value after its VBloc vagal blocking therapy system fails to meet endpoints in a pivotal trial. Wall Street fled in droves after weight-loss devices maker EnteroMedics (NSDQ:ETRM) announced that its Maestro vagal blocking system failed to meet endpoints in a pivotal study, but the mass exodus isn't discouraging the company from moving forward with a bid for FDA approval.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.